Table 2 Univariate analyses for prediction of missed diagnosis HSIL+ in patients with LSIL diagnosed by colposcopy biopsy in the training set
Parameter | Numbers | OR (95%CI) | p-values | |
|---|---|---|---|---|
Total | Missed diagnosis | |||
(%) | ||||
Age (years) | 0.654 (0.370–1.156) | 0.143 | ||
< 50 | 211 | 29 (13.7%) | ||
≥ 50 | 143 | 28 (19.6%) | ||
Menopause | 0.883 (0.490–1.592) | 0.68 | ||
No | 232 | 36 (15.5%) | ||
Yes | 122 | 21 (17.2%) | ||
HPV-16/18 infection | 2.813 (1.569–5.042) | 0 | ||
No | 255 | 30 (11.8%) | ||
Yes | 99 | 27 (27.3%) | ||
Multiple HR-HPV infection | 1.992 (1.118–3.549) | 0.018 | ||
No | 240 | 31 (12.9%) | ||
Yes | 114 | 26 (22.8%) | ||
TZ types | 2.368 (1.305–4.296) | 0.004 | ||
TZ1/2 | 265 | 34 (13.3%) | ||
TZ3 | 89 | 23 (26.1%) | ||
Lesion range | 2.369 (1.285–4.366) | 0.005 | ||
< 3 | 166 | 17 (10.2%) | ||
≥ 3 | 188 | 40 (21.3%) | ||
TCT ≥ ASC-H | 11.200 (4.762–26.340) | < 0.001 | ||
NO | 328 | 41 (12.5%) | ||
Yes | 26 | 16 (61.5%) | ||
Colposcopic impression | 9.743 (4.765–19.921) | < 0.001 | ||
Normal/G1 | 314 | 35 (11.2%) | ||
G2 | 40 | 22 (55%) | ||
Immune disease | 0.806 (0.367–1.772) | 0.591 | ||
No | 306 | 48 (15.7%) | ||
Yes | 48 | 9 (18.8%) | ||
Smoking | 0.571 (0.232–1.409) | 0.219 | ||
No | 325 | 50 (15.4%) | ||
Yes | 29 | 7 (24.1%) | ||
Gravidity | 1.185 (0.657–2.137) | 0.573 | ||
< 3 | 119 | 21 (17.6%) | ||
≥ 3 | 235 | 36 (15.3%) | ||
Parity | 0.921 (0.516–1.642) | 0.78 | ||
< 2 | 217 | 34 (15.7%) | ||
≥ 2 | 137 | 23 (16.8%) | ||
Hormone use | 0.556(0.163–1.897) | 0.342 | ||
No | 324 | 54 (16.7) | ||
Yes | 30 | 10 (10%) | ||